95 related articles for article (PubMed ID: 19272797)
1. Hormonal and pathologic changes after chemoablation of testes with hypertonic saline solution as a treatment method alternative to orchiectomy in patients with hormone sensitive metastatic prostatic cancer.
Emir L; Sunay M; Yalbuzdağ O; Karakaya Y; Erol D
Urol Oncol; 2011; 29(2):212-7. PubMed ID: 19272797
[TBL] [Abstract][Full Text] [Related]
2. Chemical castration with intratesticular injection of 20% hypertonic saline: a minimally invasive method.
Emir L; Dadali M; Sunay M; Erol D; Caydere M; Ustün H
Urol Oncol; 2008; 26(4):392-6. PubMed ID: 18367099
[TBL] [Abstract][Full Text] [Related]
3. Bilateral orchidectomy in three metastatic prostate cancer patients with failed LHRH-agonist therapy.
Olapade-Olaopa EO; Oluwasola AO; Shonibare A; Falebita OA; Akang EE; Shokunbi MT
S Afr Med J; 2006 Sep; 96(9):810-1. PubMed ID: 17068650
[No Abstract] [Full Text] [Related]
4. Hormonal treatment of prostate cancer.
Garnick MB
N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
[No Abstract] [Full Text] [Related]
5. Hormonal treatment alone for locally advanced prostate cancer.
Mottet N
BJU Int; 2004 Dec; 94 Suppl 3():14-5. PubMed ID: 15521888
[No Abstract] [Full Text] [Related]
6. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
Zhang XZ; Donovan MP; Williams BT; Mohler JL
Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
[TBL] [Abstract][Full Text] [Related]
7. Re: Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
Guess B; Scholz M
J Urol; 2001 May; 165(5):1644-5. PubMed ID: 11345950
[No Abstract] [Full Text] [Related]
8. Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer.
Rocco B; Ferrari M; Scardino E; Matei DV; Verweij F; Varela R; De Cobelli O
Anticancer Res; 2005; 25(1B):577-8. PubMed ID: 15816630
[TBL] [Abstract][Full Text] [Related]
9. [Diferelin treatment of primary local and generalized cancer of the prostate].
Kolesnikov GP; Rusakov IG; Shaplygin LV; Voznesenskiĭ SA; Bystrov AA
Urologiia; 2001; (6):17-9. PubMed ID: 11785073
[No Abstract] [Full Text] [Related]
10. [Hormonal treatment of cancer of the prostate: review and present status].
Ganzer R; Wieland WF; Bach T; Rössler W; Blana A
Dtsch Med Wochenschr; 2007 Jan; 132(4):161-6. PubMed ID: 17230333
[No Abstract] [Full Text] [Related]
11. [LHRH analogues for the treatment of prostate cancer: an evidence level-based analysis].
Pfitzenmaier J; Altwein JE
Aktuelle Urol; 2009 Mar; 40(2):100-8. PubMed ID: 19253209
[TBL] [Abstract][Full Text] [Related]
12. The fate of the medically castrated testis: expectation versus reality.
Issa MM; Krishnan A; Bouet R; Young MR; Hood N; Petros JA
J Urol; 2004 Sep; 172(3):1042-4. PubMed ID: 15311033
[TBL] [Abstract][Full Text] [Related]
13. [Managing side effects of androgene deprivation in prostate cancer].
Thalgott M; Gschwend JE; Retz M
MMW Fortschr Med; 2010 Oct; 152(41):40-3. PubMed ID: 21090376
[No Abstract] [Full Text] [Related]
14. [Clinical studies of subcapsular orchiectomy with an intracapsular testicular prosthesis--improving the quality of life in patients with prostatic cancer].
Sakamoto M; Ikeuchi T; Kai Y
Gan No Rinsho; 1989 Sep; 35(10):1143-8. PubMed ID: 2506386
[TBL] [Abstract][Full Text] [Related]
15. Use of hormonal therapy in men with metastatic prostate cancer.
Lu-Yao G; Moore DF; Oleynick J; Dipaola RS; Yao SL
J Urol; 2006 Aug; 176(2):526-31. PubMed ID: 16813882
[TBL] [Abstract][Full Text] [Related]
16. [A new surgical technic as a substitute for orchiectomy in the treatment of prostate cancer].
Romero Maroto J; Verdú Tartajo F
Actas Urol Esp; 1983; 7(1):7-16. PubMed ID: 6880903
[No Abstract] [Full Text] [Related]
17. Mitomycin C for metastatic prostate cancer: final analysis of a randomized trial.
Boel K; Van Poppel H; Goethuys H; Derluyn J; Vandenbroucke F; Popelier G; Casselman J; Billiet I; Vanuytsel L; Paridaens R; Baert L
Anticancer Res; 1999; 19(3B):2157-61. PubMed ID: 10472324
[TBL] [Abstract][Full Text] [Related]
18. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
[TBL] [Abstract][Full Text] [Related]
19. Testosterone measurement in patients with prostate cancer.
Schulman CC; Irani J; Morote J; Schalken JA; Montorsi F; Chlosta PL; Heidenreich A
Eur Urol; 2010 Jul; 58(1):65-74. PubMed ID: 20434831
[TBL] [Abstract][Full Text] [Related]
20. Early androgen deprivation for prostate cancer?
Eisenberger MA; Walsh PC
N Engl J Med; 1999 Dec; 341(24):1837-8. PubMed ID: 10588970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
